Cutaneous Angiosarcoma: A Single-Institution Experience
Authors:
- 9 July 2013
- journal article
- clinical trial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 20 (11) , 3391-3397
Abstract
Cutaneous angiosarcoma (CAS) is a rare, aggressive vascular sarcoma with a poor prognosis, historically associated with 5-year overall survival (OS) ratesKeywords
This publication has 23 references indexed in Scilit:
- Surgical management of radiation-associated cutaneous breast angiosarcomaJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalpHead & Neck, 2010
- Do Radiation-Associated Soft Tissue Sarcomas Have the Same Prognosis As Sporadic Soft Tissue Sarcomas?Journal of Clinical Oncology, 2010
- Surgical Treatment of Angiosarcoma of the ScalpAnnals of Plastic Surgery, 2008
- Treatment and Outcome of 82 Patients with AngiosarcomaAnnals of Surgical Oncology, 2007
- A 14-Year Retrospective Review of AngiosarcomaThe Cancer Journal, 2005
- Cutaneous angiosarcoma: a case series with prognostic correlationJournal of the American Academy of Dermatology, 2004
- Radiation therapy for angiosarcomaHead & Neck, 2003
- Cutaneous angiosarcoma of the scalpCancer, 2003
- Clinical Aspects of Postirradiation Sarcomas1JNCI: Journal of the National Cancer Institute, 1988